Ovid Therapeutics(DE:1OT)
€2.480.00 (0.00%)
DE:1OT
Ovid Therapeutics Revenue
€2.48
At close:0.00 (0.00%)
Ovid Therapeutics (1OT) Revenue
6 Followers
Ovid Therapeutics Revenue
Ovid Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 1.45M, Decreased 8.34%. In the fiscal year ending Dec 31, 2025, Ovid Therapeutics had annual revenue of 7.25M with 1181.27% growth.
- Revenue (ttm)
- 1.45M
- Revenue Growth
- -78.65%
- P/S Ratio
- 67.95
- Revenue/Employee
- EUR 315,304
- Employees
- 23
- Market Cap
- EUR 492.80M
Revenue Chart
Ovid Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.25M | 6.69M | 1181.27% |
| Dec 31, 2024 | 566.00K | 174.00K | 44.39% |
| Dec 31, 2023 | 392.00K | -1.11M | -73.91% |
| Dec 31, 2022 | 1.50M | -206.88M | -99.28% |
| Dec 31, 2021 | 208.38M | 195.77M | 1551.57% |
| Dec 31, 2020 | 12.62M | 12.62M | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.